Abbott Laboratories
SIX:ABT
Abbott Laboratories
SIX:ABT
Precio:
91,0424
CHF
-4,17%
Mercado cerrado
Capitalización de mercado:
CHf158,20 B
Agregar nota
Añadir objetivo
Captura tus ideas y establece un objetivo
Decide a qué precio te sentirías cómodo comprando y te ayudaremos a estar preparado.
Basado en
Margen de seguridad
0%
10%
20%
30%
40%
50%
Tu precio objetivo
Vinculado a
precio actual
· En zona de compra
Cargando
Nota vinculada
Elige la acción que deseas seguir con un precio objetivo
Vistos recientemente
|
A
|
Abbott Laboratories
SIX:ABT
|
US |
|
D
|
Dr Ing hc F Porsche AG
SWB:P911
|
DE |
|
British American Tobacco PLC
LSE:BATS
|
UK |
|
Cross-Harbour Holdings Ltd
OTC:CRHHF
|
HK |
|
Wal Mart de Mexico SAB de CV
BMV:WALMEX
|
MX |
|
Hydrocarbon Dynamics Ltd
ASX:HCD
|
AU |
|
D
|
Deere & Co
SWB:DCO
|
US |
|
A
|
Asahi Holdings Inc
XBER:A19
|
JP |
|
Parkmead Group PLC
F:LYK1
|
UK |
|
Ebusco Holding NV
F:8J3
|
NL |
|
C
|
China Coal Energy Co Ltd
SWB:CVV
|
CN |
|
SunPower Corp
NASDAQ:SPWR
|
US |
|
H
|
Harmony Gold Mining Company Ltd
SWB:HAM1
|
ZA |
|
Danone SA
F:BSND
|
FR |
|
BBMG Corp
F:9BM
|
CN |
|
Mitsui Fudosan Co Ltd
F:MFU
|
JP |
|
H
|
HeidelbergCement AG
LSE:0MG2
|
DE |
Reverse DCF
Market Expectations:
Unrealistic
To justify the current price, Netflix Inc. must grow revenue by 36% annually over the next 5 years, which is outside the range of what's considered realistic.
| Revenue Growth Rate | DCF Value | |
|---|---|---|
|
Realistic Range
|
Realistic Low: 10%
|
$601.26
Overvalued by 45%
|
|
Historical: 21%
|
$758.26
Overvalued by 36%
|
|
|
Current DCF: 23%
|
$789.44
Overvalued by 32%
|
|
|
Wall Street: 24%
|
$831.32
Overvalued by 28%
|
|
|
Realistic High: 30%
|
$900.12
Overvalued by 12%
|
|
|
Implied by Price: 36%
|
$977.59
Matches Stock Price
|
Below current price
Above current price
